These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 22474711

  • 1. Encouraging news about ADHD drugs and heart risk in adults.
    Harv Ment Health Lett; 2012 Mar; 28(9):7. PubMed ID: 22474711
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC.
    Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ADHD pharmacotherapy: rates of stimulant use and cardiovascular risk.
    Kratochvil CJ.
    Am J Psychiatry; 2012 Feb; 169(2):112-4. PubMed ID: 22318789
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Priapism - side effect of methylphenidate].
    Aktuelle Urol; 2014 Mar; 45(2):94. PubMed ID: 24700059
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T, Patsopoulos NA, Weiser M.
    Cochrane Database Syst Rev; 2016 May 26; (5):CD005041. PubMed ID: 27228176
    [No Abstract] [Full Text] [Related]

  • 14. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC, Cox DJ.
    J Psychopharmacol; 2008 May 26; 22(3):227-9. PubMed ID: 18541623
    [No Abstract] [Full Text] [Related]

  • 15. ADHD update: new data on the risks of medication.
    Harv Ment Health Lett; 2006 Oct 26; 23(4):3-5. PubMed ID: 17183739
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason.
    Batra AS, Alexander ME, Silka MJ.
    Pediatr Cardiol; 2012 Mar 26; 33(3):394-401. PubMed ID: 22298228
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C.
    Rev Infirm; 2009 Jun 26; (151):47-9. PubMed ID: 19579855
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.